Arthur C. Butcher - Jun 1, 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP&Pres, Asia Pacific
Signature: /s/ Vance R. Brown, Attorney-in-fact
Stock symbol: BSX
Transactions as of: Jun 1, 2021
Transactions value $: -$29,879
Form type: 4
Date filed: 6/2/2021, 04:19 PM
Next filing: Aug 2, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+1.76K	+5.99%	$0.00	31.2K	Jun 1, 2021	Direct	F1
transaction	BSX	Common Stock	Tax liability	-$29.9K	-696	-2.23%	$42.93	30.5K	Jun 1, 2021	Direct
holding	BSX	Common Stock						2.55K	Jun 1, 2021	By 401(k)	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-1.76K	-100%	$0.00^*	0	Jun 1, 2021	Common Stock	1.76K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3	Shares of common stock will be issued to the reporting person in five equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant.